Simplifying mCSPC: Improving Patient Management and Outcomes
Feb 24, 2021•40 min•Ep. 2
Episode description
Disclosures:
Ricardo Rendon
Advisory Board: Astellas, Amgen, Abbvie, Janssen, Bayer, AstraZeneca, Ferring, Sanofi
Speakers Bureau: Astellas, Amgen, Ferring, Janssen
Clinical Trials: Amgen, Astellas, Abbvie, Ferring, Janssen, AstraZeneca, Sanofi, Pfizer, Myovant
For the best experience, listen in Metacast app for iOS or Android
